Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Reviews in Molecular Medicine|May 11, 2006
Pathophysiology and therapy for haemoglobinopathies. Part II: thalassaemiasFabrizia Urbinati, Catherine Madigan, Punam Malik
Human Gene Therapy|May 27, 2005
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptorFabrizia Urbinati, Francesco Lotti, Giulia Facchini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTRFabrizia Urbinati, Paritha Arumugam, Tomoyasu Higashimoto, et al.
Blood|May 29, 2009
A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correctionAjay Perumbeti, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.
Plos One|September 12, 2009
The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activityParitha I Arumugam, Fabrizia Urbinati, Chinavenmeni S Velu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2017
Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem CellsKatelyn E Masiuk, Devin Brown, Jennifer Laborada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control regionParitha I Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.
Stem Cells (Dayton, Ohio)|January 16, 2015
Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapyKismet Baldwin, Fabrizia Urbinati, Zulema Romero, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell DiseaseValentina Poletti, Fabrizia Urbinati, Sabine Charrier, et al.
Human Gene Therapy|September 11, 2018
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison StudyFabrizia Urbinati, Beatriz Campo Fernandez, Katelyn E Masiuk, et al.
Pageof 3